F
Foundation Medicine
Transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease
At a glance
- Status
- Listed
- Listing
- IPO 2013
News
Open roles
Foundation Medicine in the Boston ecosystem
The Foundation Medicine office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Series B and later9 investors entered at this stage
- HSHarvard Medical School
- RGRedmile Group
- HUHarvard University
- BGBill Gates
Casdin Capital- RFRoche Venture Fund
- BIBroad Institute
- EJEvan Jones
- DIDana-Farber Cancer Institute
Source: Dealroom Talent Intelligence.
Global footprint
Patents
140 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Foundation Medicine was the backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Foundation Medicine's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Foundation Medicine's portfolio, mapped.
See Foundation Medicine on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.



